4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Alcoholic Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balbo, S; de la Monte, SM; Deochand, C; Hecht, S; Nunez, K; Ramirez, T; Silbermann, E; Tong, M; Yalcin, EB; Yu, R; Zabala, V | 1 |
1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Alcoholic Liver Diseases
| Article | Year |
|---|---|
Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.
Topics: Alcoholism; Animals; Binge Drinking; Carcinogens; Central Nervous System Depressants; Disease Models, Animal; Endoplasmic Reticulum; Ethanol; Fatty Liver, Alcoholic; Hepatocytes; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Liver; Liver Diseases, Alcoholic; Mitochondria, Liver; Necrosis; Nitrosamines; Rats; Rats, Long-Evans; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction | 2015 |